Loading...
Loading...
India's ciprofloxacin imports from UNITED STATES total $518.1K across 76 shipments from 15 foreign suppliers. PAR STERILE PRODUCTS leads with $116.8K in import value; the top 5 suppliers together control 66.1% of this origin. Leading Indian buyers include INDOCO REMEDIES LIMITED. This corridor reflects India's pharmaceutical import demand for ciprofloxacin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

PAR STERILE PRODUCTS is the leading Ciprofloxacin supplier from UNITED STATES to India, with import value of $116.8K across 2 shipments. The top 5 suppliers — PAR STERILE PRODUCTS, ESPEE BIOPHARMA & FINECHEM LLC, AGRACE PHARMA., AMSTERDAM PHARMA(APTEKA RX INC.), AMSTERDAM PHARMA(APTEKA RX INC) — collectively account for 66.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PAR STERILE PRODUCTS | $116.8K | 2 | 22.5% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $71.2K | 3 | 13.7% |
| 3 | AGRACE PHARMA. | $70.8K | 3 | 13.7% |
| 4 | AMSTERDAM PHARMA(APTEKA RX INC.) | $48.2K | 5 | 9.3% |
| 5 | AMSTERDAM PHARMA(APTEKA RX INC) | $35.5K | 2 | 6.9% |
| 6 | BILCARE GCS INC. | $33.7K | 2 | 6.5% |
| 7 | ESPEE BIOPHARMA & FINECHEM LLC. | $30.0K | 1 | 5.8% |
| 8 | PHARMAQUELLE LLC | $17.8K | 1 | 3.4% |
| 9 | AMSTERDAM PHARMA | $16.5K | 2 | 3.2% |
| 10 | RAFF & HALL PHARMACY | $13.4K | 3 | 2.6% |
| 11 | REGIONAL PHARMACY | $12.2K | 4 | 2.4% |
| 12 | AGRACE PHARMA | $7.5K | 7 | 1.4% |
| 13 | NEW LIFE MEDICALS (USA) INC. | $4.7K | 2 | 0.9% |
| 14 | ESPEE BIOPHARMA FINECHEM LLC | $4.5K | 1 | 0.9% |
| 15 | NEW LIFE MEDICALS (USA) INC | $4.1K | 2 | 0.8% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INDOCO REMEDIES LIMITED | $124.4K | 10 | 24.0% |
| 2 | PAR FORMULATIONS PRIVATE LIMITED | $116.8K | 2 | 22.5% |
| 3 | AUROBINDO PHARMA LTD | $75.4K | 7 | 14.5% |
| 4 | MANKIND PHARMA LIMITED | $50.8K | 9 | 9.8% |
| 5 | DR.REDDY'S LABORATORIES LTD | $48.4K | 5 | 9.4% |
| 6 | MICRO LABS LIMITED | $47.8K | 2 | 9.2% |
| 7 | MANKIND PHARMA LTD | $16.5K | 2 | 3.2% |
| 8 | FDC LIMITED | $13.9K | 4 | 2.7% |
| 9 | HETERO LABS LIMITED | $4.7K | 4 | 0.9% |
| 10 | HETERO LABS LIMITED | $4.1K | 2 | 0.8% |
| 11 | DR REDDY S LABORATORIES LIMITED | $3.8K | 2 | 0.7% |
| 12 | DR REDDYS LABORATORIES LIMITED | $3.3K | 3 | 0.6% |
| 13 | AUROBINDO PHARMA LIMITED | $3.1K | 3 | 0.6% |
| 14 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | $1.7K | 2 | 0.3% |
| 15 | DR.REDDY'S LABORATORIES LIMITED | $1.0K | 1 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Ciprofloxacin suppliers from UNITED STATES to India include PAR STERILE PRODUCTS, ESPEE BIOPHARMA & FINECHEM LLC, AGRACE PHARMA.. The leading supplier is PAR STERILE PRODUCTS with import value of $116.8K USD across 2 shipments. India imported Ciprofloxacin worth $518.1K USD from UNITED STATES in total across 76 shipments.
India imported Ciprofloxacin worth $518.1K USD from UNITED STATES across 76 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Ciprofloxacin sourced from UNITED STATES include INDOCO REMEDIES LIMITED, PAR FORMULATIONS PRIVATE LIMITED, AUROBINDO PHARMA LTD. The largest buyer is INDOCO REMEDIES LIMITED with $124.4K in imports across 10 shipments.
The total value of Ciprofloxacin imports from UNITED STATES to India is $518.1K USD, across 76 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
76 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists